Evidence map›Paper›PMID 34422615›Full record

ArticleIranian journal of nursing and midwifery research

The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.

Samira Foji, Eesa Mohammadi, Akram Sanagoo, Leila Jouybari

Abstract read
In one paragraph

Article in Iranian journal of nursing and midwifery research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. How do people with neurofibromatosis type 1 (the forgotten victims) live? A grounded theory study.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samira FojiSchool of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran.
Eesa MohammadiDepartment of Nursing, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Akram SanagooSchool of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran.
Leila JouybariNursing Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeurofibromatosis Type 1 (NF1) is a common autosomal disorder; the criteria for the diagnosis of NF1 includes café au lait spots, freckling, and Neurofibromas (NF). Skin symptoms have a major impact on patients' Quality of Life (QOL) but little is known about the burden of the disease on patients. The aim of this study was to explore the experiences of patients with NF. MATERIALS AND

methodsUsing purposive sampling, 20 participants were enrolled in this qualitative content analysis study. The study was carried out between 2019 and 2020. Unstructured interviews and field notes were used to gather data. Data collection was stopped when data saturation was achieved.

resultsData analysis revealed 14 subcategories and 4 categories including "failing and falling behind in life", "deprivation and restriction", "social isolation", and "ineffective adaptation to the disease", which indicate the perception of patients with NF.

conclusionsIn addition to the physical burden due to physical complications and problems, NF imposes a high degree of psychological and social burden on patients causing mental conflicts, which in turn results in them failing and falling behind in life. These findings illustrate the need to develop strategies and use multidisciplinary approaches to support patients, and thus to reduce the burden of NF.

Indexed as

Global burden of diseaseIranneurofibromatosis 1qualitative research

Identifiers

PMID34422615
PMCPMC8344627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.